GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Cyclically Adjusted Price-to-FCF

Vicplas International (SGX:569) Cyclically Adjusted Price-to-FCF : (As of May. 21, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vicplas International Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Vicplas International's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Cyclically Adjusted Price-to-FCF Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.69 58.03 74.32 459.40 63.51

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 459.40 - 63.51 -

Competitive Comparison of Vicplas International's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Vicplas International's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vicplas International's Cyclically Adjusted Price-to-FCF falls into.



Vicplas International Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Vicplas International's Cyclically Adjusted FCF per Share for the fiscal year that ended in Jul23 is calculated as:

For example, Vicplas International's adjusted Free Cash Flow per Share data for the fiscal year that ended in Jul23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jul23 (Change)*Current CPI (Jul23)
=0.024/128.9743*128.9743
=0.024

Current CPI (Jul23) = 128.9743.

Vicplas International Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201407 -0.023 100.520 -0.030
201507 0.009 100.691 0.012
201607 0.018 101.524 0.023
201707 0.005 103.278 0.006
201807 -0.011 106.324 -0.013
201907 -0.012 108.250 -0.014
202007 0.011 109.318 0.013
202107 0.007 115.183 0.008
202207 -0.005 125.002 -0.005
202307 0.024 128.974 0.024

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vicplas International  (SGX:569) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Vicplas International Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Vicplas International's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines